What is Applied Biologics?
Applied Biologics is a fully-integrated life sciences entity focused on the research, development, manufacturing, and distribution of medical technologies. The company's core expertise lies in regenerative medicine, highlighted by its flagship product, XWRAP, a dehydrated amniotic membrane allograft. XWRAP serves as a protective barrier and wound covering for both acute and chronic wounds. Applied Biologics is committed to advancing patient outcomes through rigorous clinical investigation and high-quality manufacturing, partnering with healthcare providers and wound care centers nationwide to deliver effective biologic solutions and clinical support.
How much funding has Applied Biologics raised?
Applied Biologics has raised a total of $391K across 2 funding rounds:
Debt
$150K
Debt
$241K
Debt (2020): $150K with participation from PPP
Debt (2021): $241K led by PPP
Key Investors in Applied Biologics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Applied Biologics?
With substantial late-stage funding, Applied Biologics is poised for significant expansion. The strategic investment will likely fuel further research and development into novel regenerative therapies, enhance manufacturing capabilities to meet growing demand, and broaden market penetration across healthcare networks. The company's focus on proven products and comprehensive clinical support positions it for continued growth and leadership in the regenerative medicine landscape.
See full Applied Biologics company page
